Sanofi US Educational Grants
Sanofi US is committed to funding high quality educational activities and materials in the therapeutic areas of interest to the company that have the potential to improve patient care and health outcomes.
The purpose of an educational grant is to support an activity that encourages an educational interchange with respect to available scientific and medical information. Educational activities may or may not be accredited.
All USERS must create a USER ID and Password to access the Sanofi US Educational Grants Portal. For ease of registration and application, a Practical Working Guide
is located in the lower left hand corner of this page.
Please contact Customer Support
if questions or assistance is needed.
Important to Note:
- Educational grant requests must be submitted at least 12-16 weeks in advance of the request for notification date. Please utilize the notification date to ensure your grant is reviewed within the timeframe necessary for you to be able to disclose funding in a compliant fashion. The production start date is the date activity development begins, which will differ from the launch date.
- Review and processing time will take approximately 6-8 weeks. Complete, accurate and detailed information is required to avoid delays. Applications with insufficient information may require additional processing time.
- Please refer to the FAQ
Section of this website for Eligibility
requirements, General Educational Request
information, and the Fellowship Application Process
prior to your educational grant request.
RFPs and Areas of Interest
Currently available Requests for Proposals (RFPs)
Sanofi US is currently accepting educational grant applications in the following therapeutic area(s):
- US Cardiovascular, specific to the Area of Interest:
- The role of AADs in Early Rhythm Control and the Management of Atrial Fibrillation
- US and Global Multiple Sclerosis, specific to the Area of Interest:
- US and Global Oncology, specific to the Area of Interest:
- Multiple Myeloma
- Breast Cancer
- US Oncology, specific to the following Areas of Interest:
- Prostate Cancer
- Tumor Lysis
- HSCT: stem cell mobilization and collection during autologous HSCT
- US and Global Rare Blood Disorder, specific to the Areas of Interest:
- Cold Agglutinin Disease (CAD)
- Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
- Immune Thrombocytopenia (ITP)
- US Rare Genetic Diseases, specific to the Areas of Interest:
- Acid sphingomyelinase deficiency (ASMD)
- Fabry Disease
- Gaucher Disease
- Pompe Disease
- Lysosomal Storage Disorders
- Other Genetic Disorders
- US Transplantation, specific to the Area of Interest:
- Immunosuppressive Strategies to Reduce Transplant Rejection
The Sanofi-Regeneron Alliance is currently accepting educational grant submissions in the following therapeutic area(s):
- US and Global Immunology, specific to the following Area(s) of Interest:
- Atopic Dermatitis
- Chronic Spontaneous Urticaria (CSU)
- Prurigo Nodularis (PN)
- US and Global Immunology/Respiratory, specific to the following Area of Interests, will be managed by Regeneron and should be submitted via https://mededgrants.regeneron.com
starting December 2020:
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
- Eosinophilic Esophagitis (EoE)
Sanofi US is not currently accepting educational grant applications in the following Therapeutic Areas:
- US Immunology, specific to the Area of Interest:
- US Diabetes, specific to the Area of Interest:
- Complementary insulin combinations to achieve HbA1c targets
- Long Acting Insulins with a physiologic approach to glucose control
- US Renal
- US Osteoarthritis
© 2002-2017 sanofi-aventis U.S. LLC. All rights reserved.
Questions or Comments?
to contact us.